comparemela.com

Latest Breaking News On - Capital investment advisors - Page 5 : comparemela.com

Sollinda Capital Management LLC Purchases New Position in MercadoLibre, Inc (NASDAQ:MELI)

Sollinda Capital Management LLC purchased a new stake in MercadoLibre, Inc. (NASDAQ:MELI – Free Report) in the 4th quarter, HoldingsChannel reports. The firm purchased 222 shares of the company’s stock, valued at approximately $349,000. Several other institutional investors and hedge funds have also recently modified their holdings of MELI. Atria Wealth Solutions Inc. boosted its […]

Allen Wealth Management LLC Takes Position in Northrop Grumman Co (NYSE:NOC)

Allen Wealth Management LLC bought a new stake in shares of Northrop Grumman Co. (NYSE:NOC – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 988 shares of the aerospace company’s stock, valued at approximately $463,000. Several other hedge funds have […]

Altria Group, Inc (NYSE:MO) Shares Sold by KPP Advisory Services LLC

KPP Advisory Services LLC cut its stake in shares of Altria Group, Inc. (NYSE:MO – Free Report) by 19.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 60,067 shares of the company’s stock after selling 14,314 shares during the period. Altria Group comprises approximately […]

Thermo Fisher Scientific Inc (NYSE:TMO) Shares Acquired by KPP Advisory Services LLC

KPP Advisory Services LLC boosted its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 18.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,071 shares of the medical research company’s stock after purchasing an additional 321 shares during […]

Humankind Investments LLC Purchases New Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Humankind Investments LLC acquired a new position in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 4,500 shares of the financial services provider’s stock, valued at approximately $611,000. A number of other hedge funds also recently modified […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.